Lantern Pharma (LTRN)

• Market cap: $41.1M
• 1 day: -0.52%
• 5 days: -6.39%
• 1 month: -16.63%
• 3 months: 19.06%
• 6 months: -3.05%
• Year to date: 15.45%
• 1 year: 1.33%
• 5 years: -78.64%
• 10 years: -74.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Employees: 24

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

800% more call options, than puts

Call options by funds: $108K | Put options by funds: $12K

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 31 [Q1] → 33 (+2) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

1.68% less ownership

Funds ownership: 22.46% [Q1] → 20.78% (-1.68%) [Q2]

18% less capital invested

Capital invested by funds: $8.59M [Q1] → $7.08M (-$1.51M) [Q2]